DHAP PROTOKOLÜ

Kaynaklar:

1- Crump, M., J. Kuruvilla, S. Couban, et al. 2014. "Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12." J Clin Oncol 32(31):3490-3496.

2- Moccia, A., F. Hitz, P. Hoskins et al. 2017. "Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma." Leuk Lymphoma. 2017 Feb;58(2):324-332.

3-Velasquez, W. S., F. Cabanillas, P. Salvador, et al. 1988. "Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)." Blood. 71(1):117-122.

4-Delarue, R., C. Haioun, V. Ribrag, et al. 2013. "CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte." Blood 121(1):48-53.

5-de Guibert, S., A. Jaccard, M. Bernard, et al. 2006. "Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma." Haematologica 91(3):425-426.